Tag: FDA

FDA: Edge Pharma issues nationwide recall of all drug products

Editor's Note The Food and Drug Administration (FDA) on December 7 announced that Edge Pharma, LLC (Colchester, Vermont) has issued a nationwide recall of all drug products. The recall was initiated because of process issues that could lead to a lack of sterility assurance for products intended to be sterile…

Read More

By: Judy Mathias
December 9, 2021
Share

Change in volume of surgical procedures during COVID-19 pandemic

Editor's Note In this study, researchers from Stanford University School of Medicine find that the initial COVID-19 shutdown from March through April 2020 resulted in a decrease in surgical volume to nearly half of baseline rates. After the reopening, surgical volume rebounded to 2019 levels, and the trend was maintained.…

Read More

By: Judy Mathias
December 8, 2021
Share

FDA: Class I recall of Teleflex percutaneous thrombolytic device kit

Editor's Note The Food and Drug Administration (FDA), on November 30, identified the worldwide recall by Teleflex of its Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7FR as Class I, the most serious. The device, which is used for mechanical declotting of native arteriovenous fistulae and synthetic dialysis grafts, was…

Read More

By: Judy Mathias
December 2, 2021
Share

FDA: Nationwide recall of certain SterRx drug products

Editor's Note The Food and Drug Administration (FDA), on November 15, announced the nationwide recall by SterRx, LLC, of 240 lots of its drug products. The recall was initiated because of the lack of sterility assurance due to equipment and process issues. The recalled drugs include: l mg/ml Midazolam in…

Read More

By: Judy Mathias
November 18, 2021
Share

FDA: Class I recall of Aligned Medical Solutions custom convenience kits

Editor's Note The Food and Drug Administration (FDA), on November 9, identified the recall by Aligned Medical Solutions of its custom convenience kits as Class I, the most serious. The recall was initiated because of the potential for the plunger in Cardinal Health's Monoject Flush Prefilled Syringe (0.9% sodium chloride),…

Read More

By: Judy Mathias
November 11, 2021
Share

FDA investigating imported surgical, exam gloves

Editor's Note The Food and Drug Administration (FDA), on September 29, announced that healthcare facilities and providers should not purchase or use imported surgical and patient examination gloves from companies included on Import Alert 80-04. Companies are listed on an import alert when the FDA has enough evidence that they…

Read More

By: Judy Mathias
November 3, 2021
Share

FDA: Class I recall of Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pump battery packs

Editor's Note The Food and Drug Administration (FDA), on October 29, identified the recall by Datascope/Getinge/Maquet of its Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pump battery packs as Class I, the most serious. The recall was initiated because of the risk of the battery failing and having a shortened run time, which…

Read More

By: Judy Mathias
November 1, 2021
Share

FDA: Class I recall of DeRoyal procedure packs containing Smiths Medical Normoflo irrigation warming sets

Editor's Note The Food and Drug Administration (FDA), on October 6, identified the recall by Deroyal Industries of its procedure packs containing Smiths Medical Normoflo irrigation warming sets as Class I, the most serious. The recall was initiated because of the possibility of harmful levels of aluminum leaching into the…

Read More

By: Judy Mathias
October 28, 2021
Share

ECRI issues statement on COVID-19 vaccine boosters, global vaccine equity

Editor's Note In an October 26 news release, ECRI announced the publication of a Position Statement on “COVID-19 Vaccines: Mitigating Disease and Promoting Global Health Equity.” Speaking in support of the Statement, Marcus Schabacker, MD, PhD, president and chief executive officer, ECRI, says: “Despite the FDA and CDC’s advancement of…

Read More

By: Judy Mathias
October 27, 2021
Share

CDC expands eligibility for COVID-19 boosters

Editor's Note The Centers for Disease Control and Prevention (CDC) director Rochelle P. Walensky, MD, MPH, on October 21, endorsed the CDC Advisory Committee on Immunization Practices’ recommendation for a booster of COVID-19 vaccines in certain populations. For individuals who received Pfizer-BioNTech or Moderna COVID-19 vaccines, the following are eligible…

Read More

By: Judy Mathias
October 26, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat